TAM
TFG Asset Management Portfolio holdings
AUM
$554M
1-Year Est. Return
17.58%
1 Year Est. Return
+17.58%
AUM
$554M
AUM Growth
+$243M
(+78%)
Holding
40
Top Buys
| 1 | +$61.1M | |
| 2 | +$10.3M | |
| 3 | +$3.67M | |
| 4 |
Tarsus Pharmaceuticals
TARS
|
+$2.9M |
| 5 |
AUTL
Autolus Therapeutics
AUTL
|
+$2.05M |
Top Sells
| 1 | +$14M | |
| 2 | +$867K | |
| 3 | +$798K | |
| 4 |
Keros Therapeutics
KROS
|
+$734K |
| 5 |
Cameco
CCJ
|
+$150K |
Sector Composition
| 1 | Technology | 40.13% |
| 2 | Healthcare | 13.37% |
| 3 | Energy | 9.04% |
| 4 | Materials | 0.3% |
| 5 | Consumer Staples | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
UiPath
PATH
$8.46B
| $176M | 28.3% |
13,722,244
+4,772,244
|
|
||
|
KGEI
2
Kolibri Global Energy
KGEI
$176M
| $48.7M | 7.84% |
7,068,857
-1,711
|
|
||
|
AUTL
3
Autolus Therapeutics
AUTL
$447M
| $21.7M | 3.49% |
9,500,000
+900,000
|
|
||
4
Sprinklr
CXM
$1.85B
| $18.6M | 3% |
2,200,000
|
|
||
5
Lyft
LYFT
$8.25B
| $15.8M | 2.54% |
1,000,000
|
|
||
6
Workiva
WK
$4.89B
| $10.3M | 1.65% |
+150,000
|
|
||
|
7
Tarsus Pharmaceuticals
TARS
$3.16B
| $10.1M | 1.63% |
250,000
+71,530
|
|
||
8
Annexon
ANNX
$348M
| $6.74M | 1.09% |
2,810,000
+160,000
|
|
||
9
Celldex Therapeutics
CLDX
$1.76B
| $6.43M | 1.04% |
316,150
+55,150
|
|
||
10
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$18.1B
| $5.54M | 0.89% |
68,660
+5,518
|
|
||
|
TECX
11
Tectonic Therapeutic
TECX
$330M
| $4.55M | 0.73% |
228,832
+41,332
|
|
||
12
Axsome Therapeutics
AXSM
$6.24B
| $4.34M | 0.7% |
41,531
+7,725
|
|
||
13
Scholar Rock
SRRK
$2.83B
| $3.67M | 0.59% |
+103,482
|
|
||
14
Acadia Pharmaceuticals
ACAD
$3.48B
| $3.48M | 0.56% |
161,396
+54,396
|
|
||
15
Pharvaris
PHVS
$1.41B
| $3.31M | 0.53% |
188,100
+61,105
|
|
||
16
Relay Therapeutics
RLAY
$1.12B
| $2.42M | 0.39% |
699,000
+80,000
|
|
||
17
Immunovant
IMVT
$3.03B
| $2.37M | 0.38% |
147,817
+16,650
|
|
||
18
Snowflake
SNOW
$81.3B
| $2.24M | 0.36% |
10,000
|
|
||
|
19
Keros Therapeutics
KROS
$558M
| $1.71M | 0.28% |
128,000
-55,000
|
|
||
|
20
Cameco
CCJ
$39.7B
| $1.43M | 0.23% |
19,280
-2,020
|
|
||
21
Amylyx Pharmaceuticals
AMLX
$1.62B
| $1.4M | 0.23% |
+218,750
|
|
||
22
Dyne Therapeutics
DYN
$2.34B
| $1.32M | 0.21% |
+138,375
|
|
||
23
Hudbay
HBM
$6.83B
| $1.14M | 0.18% |
107,000
|
|
||
24
Alkermes
ALKS
$5.08B
| $447K | 0.07% |
+15,632
|
|
||
25
Sociedad Química y Minera de Chile
SQM
$12.7B
| $272K | 0.04% |
+7,700
|
|